Vitamin D, selenium, and antidiabetic drugs in the treatment of type 2 diabetes mellitus with Hashimoto's thyroiditis

Table 3 Comparison of blood glucose index and blood lipid index pre-treatment, 3 months after treatment, and 6 months after treatment in 3 groups

Group	TC (mU/L)			TG (pmol/L)
	Pre-treatment	After 3 months of treatment	After 6 months of treatment	Pre-treatment	After 3 months of treatment	After 6 months of treatment
Control group (n = 50)	5.13 ± 0.86	4.46 ± 0.81	4.16 ± 0.77	3.21 ± 1.02	2.97 ± 0.91	2.93 ± 0.91
Test group A (n = 50)	4.98 ± 0.89	3.76 ± 0.75a	2.76 ± 0.68a	3.17 ± 0.96	2.43 ± 0.71a	1.98 ± 0.65a
Test group B (n = 50)	4.96 ± 0.92	3.07 ± 0.68a,b	2.40 ± 0.69a,b	3.16 ± 1.05	2.08 ± 0.64a,b	1.83 ± 0.60a,b
F value	0.546	43.665	84.262	0.033	17.243	32.575
P value	0.581	< 0.001	< 0.001	0.967	< 0.001	< 0.001

^aP < 0.05 vs group pre-treatment.

^bP < 0.05 vs 3 months after treatment.

TC: Total cholesterol; TG: Triacylglycerol.